Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Baxter International
(NY:
BAX
)
20.11
-0.26 (-1.28%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Baxter International
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
August 13, 2024
From
Baxter International Inc.
Via
Business Wire
The Latest Analyst Ratings For Baxter Intl
↗
August 07, 2024
Via
Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
↗
August 06, 2024
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare...
Via
Benzinga
Baxter Reports Second-Quarter 2024 Results
August 06, 2024
From
Baxter International Inc.
Via
Business Wire
Assessing Baxter Intl: Insights From 4 Financial Analysts
↗
July 02, 2024
Via
Benzinga
How Is The Market Feeling About Baxter Intl?
↗
June 07, 2024
Via
Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
↗
May 30, 2024
Via
Benzinga
3 Contrarian Stock Picks to Buy Against the Market Consensus
↗
August 05, 2024
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential.
Via
InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
↗
July 24, 2024
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private...
Via
Benzinga
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
July 17, 2024
From
Baxter International Inc.
Via
Business Wire
Baxter Declares Quarterly Dividend
July 16, 2024
From
Baxter International Inc.
Via
Business Wire
(BAX) - Analyzing Baxter Intl's Short Interest
↗
May 13, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
↗
May 10, 2024
Via
Benzinga
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 15, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
July 10, 2024
Via
Benzinga
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
July 10, 2024
From
Baxter International Inc.
Via
Business Wire
3 Bargain Bin Stocks with Millionaire-Maker Potential
↗
July 09, 2024
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks.
Via
InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
↗
July 08, 2024
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and...
Via
Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
↗
July 04, 2024
Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford.
Via
Talk Markets
Topics
Economy
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 06, 2024
From
Baxter International Inc.
Via
Business Wire
7 Deeply Undervalued Stocks to Buy Now or Regret Later
↗
June 05, 2024
Unlock massive upside by buying these deeply undervalued stocks at fire-sale prices. These companies have staying power and could bounce back.
Via
InvestorPlace
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
May 29, 2024
From
Baxter International Inc.
Via
Business Wire
3 Dividend Growth Stocks For Long-Term Returns
↗
May 24, 2024
One way to measure the quality of a dividend stock is by its dividend history. Stocks with established histories of dividend growth may be likely to continue growing their dividends moving forward....
Via
Talk Markets
Baxter to Present at Jefferies 2024 Global Healthcare Conference
May 23, 2024
From
Baxter International Inc.
Via
Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
↗
May 21, 2024
Via
Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
↗
May 17, 2024
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...
Via
Benzinga
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
May 15, 2024
From
Baxter International Inc.
Via
Business Wire
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
May 13, 2024
From
Baxter International Inc.
Via
Business Wire
Baxter to Present at Bank of America 2024 Health Care Conference
May 07, 2024
From
Baxter International Inc.
Via
Business Wire
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
